Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial

Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy

(2015) Carlos A. Morillo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Revisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts?

(2015) Marta de Lana et al.   Biomed Research International

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

(2014) Jennifer K. Rogers et al.   EUROPEAN JOURNAL OF HEART FAILURE

Chagas Disease Cardiomyopathy: Immunopathology and Genetics

(2014) Edecio Cunha-Neto et al.   MEDIATORS OF INFLAMMATION

Chagas Disease: Still Many Unsolved Issues

(2014) José M. Álvarez et al.   MEDIATORS OF INFLAMMATION

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity

(2014) Bianca Zingales et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Chagas Disease and the London Declaration on Neglected Tropical Diseases

(2014) Rick L. Tarleton et al.   PLoS Neglected Tropical Diseases

Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease

(2013) R. Viotti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

International differences in treatment effect: do they really exist and why?†

(2013) Stuart Pocock et al.   EUROPEAN HEART JOURNAL

Polymorphism in the Alpha Cardiac Muscle Actin 1 Gene Is Associated to Susceptibility to Chronic Inflammatory Cardiomyopathy

(2013) Amanda Farage Frade et al.   PLoS One

Endothelial Transmigration by Trypanosoma cruzi

(2013) Bria M. Coates et al.   PLoS One

Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements

(2013) Jose Antonio Marin-Neto et al.   Revista da Sociedade Brasileira de Medicina Tropical

Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease

(2012) Paulo Marcos Matta Guedes et al.   PLoS Neglected Tropical Diseases

Fexinidazole: A Potential New Drug Candidate for Chagas Disease

(2012) Maria Terezinha Bahia et al.   PLoS Neglected Tropical Diseases

I Diretriz Latino-Americana para o Diagnóstico e Tratamento da Cardiopatia Chagásica

(2011) Iran Castro et al.   Arquivos Brasileiros de Cardiologia

Pathogenesis of Chagas' Disease: Parasite Persistence and Autoimmunity

(2011) A. R. L. Teixeira et al.   CLINICAL MICROBIOLOGY REVIEWS

The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications

(2011) Bianca Zingales et al.   INFECTION GENETICS AND EVOLUTION

Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism

(2011) Antonio R. L. Teixeira et al.   PLoS Neglected Tropical Diseases

Chagas disease

(2010) Anis Rassi et al.   LANCET

Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis

(2009) J. A. Perez-Molina et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

(2009) Anis Rassi Jr et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

(2008) Jose Antonio Marin-Neto et al.   AMERICAN HEART JOURNAL

Chagas Heart Disease Pathogenesis: One Mechanism or Many?

(2008) Kevin Bonney et al.   CURRENT MOLECULAR MEDICINE

Current concepts in immunoregulation and pathology of human Chagas disease

(2008) Walderez O Dutra et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Further evidence of spontaneous cure in human Chagas disease

(2008) João Carlos Pinto Dias et al.   Revista da Sociedade Brasileira de Medicina Tropical